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The modulated arc (mARC) is a VMATlike rotational technique specifically designed for "burst mode" delivery of high dose rates. Only few studies have assessed the performance of this radiotherapy modality, and it is unclear how efficient it will prove for target volumes of high vs. low complexity. We therefore present a planning and delivery study for two frequent clinical applications: a relatively simple target volume for prostate cancer without lymph node involvement and a highly complex target volume for hypopharynx cancer. In each case, plan quality, treatment time and scattered dose are compared for mARC vs. IMRT using flat or flattening-filter-free (FFF) beams.
Material and Methods:
Contours were retrospectively created for 10 prostate cancer patients and 8 head-and-neck cancer patients treated at our clinic. IMRT plans were set up using 11 beams and 55 segments. mARC plans for both energies were made using one rotation for prostate and two rotations for head-and-neck patients, with 4° arclets of spaced equidistantly every 8°. The Varian Eclipse treatment planning system with the AAA dose algorithm and a 2.5 mm dose grid was used for all plans. Plan quality was assessed using PTV coverage and sparing of organs at risk. All plans were delivered on an anthropomorphic phantom, where scattered dose was measured with thermoluminescent dosimeters (TLDs), and treatment times were recorded.
Results: All plans were visually assessed by a senior radiation oncologist and were deemed acceptable for treatment. Only few significant differences were found for PTV coverage and OAR sparing. For prostate cancer plans, no significant differences in OAR sparing were found except for the bladder, which was better spared by mARC than IMRT for both beam energies. For head-and-neck cancer cases, the mARC technique achieved a higher index of conformity and better sparing of the parotids.
While differences in plan quality were minor, treatment times could be drastically reduced by the combination of mARC with FFF beams.e average treatment times for prostate cancer were reduced from 7 min for 6 MV IMRT to 2-3 min for FFF mARC. For the complex head-and-neck target volume, times were again reduced from ca. 9 min (IMRT, 6 MV) to 5:30 min (mARC, FFF 7 MV), even though FFF 7 MV required significantly more monitor units than 6 MV plans.
The scattered dose was considerably lower for the mARC as compared with IMRT for all plans. For the prostate, scattered dose was further reduced by the FFF beam energy. For hypopharynx cancer, this effect was partially obscured by the higher monitor units.
Conclusion:
Target volumes of high and of low complexity were analysed in this work. For both scenarios, the mARC technique achieved plan qualities comparable or even better than for IMRT, with a considerable reduction in treatment time (ca. 64 % for prostate and 40 % for hypopharynx) and scattered dose.
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Hippocampal-sparing radiotherapy for glioblastoma patients using the VMAT technique J. Hofmaier Purpose or Objective: To investigate the feasibility of hippocampal-sparing radiotherapy for glioblastoma patients using volumetric modulated arc therapy (VMAT). Since neurocognitive decline has been associated with hippocampal dose, hippocampal sparing could potentially improve neurological outcome of patients undergoing cranial irradiation.
Material and Methods:
Datasets of 27 patients who received 3D-CRT for glioblastoma were included in this planning study. Dose distributions for the 3D-CRT plans were calculated in Elekta Oncentra Masterplan with a pencil beam algorithm. VMAT plans were optimized using the research TPS Hyperion V2.44 (equivalent to Elekta Monaco 5.1) which relies on Monte Carlo dose calculation. It was attempted to reduce the dose to the contralateral hippocampus as much as possible without compromising other treatment parameters such as target coverage, homogeneity index, conformity index and dose to other organs at risk including brain stem, chiasm, optic nerve and lenses. Parameters for both techniques were compared applying the Wilcoxon signed-rank test. The influence of tumor localization on hippocampal dose exposure was investigated with the Mann-Whitney U test. The correlation between PTV size and hippocampal dose was assessed with Spearman's rank correlation coefficient.
Results:
With VMAT compared to 3D-CRT, the median reduction of the mean contralateral hippocampus dose was 56% (p<0.01). Other treatment parameters could be improved or at least be kept stable. Particularly, the median V30Gy of the brain was reduced from 58.7% to 48.2% (p<0.01). The median homogeneity index improved from 0.18 for 3D-CRT to 0.15 for VMAT (p<0.01), the median conformity index from 0.70 to 0.80 (p<0.01). For VMAT, a smaller PTV size correlated with improved hippocampal sparing (p= 0.01). A S782 ESTRO 35 2016 _____________________________________________________________________________________________________ parietal tumor localization was a predictor for a higher contralateral hippocampal dose (p=0.01).
Conclusion:
A substantial reduction of the dose to the contralateral hippocampus is technically feasible when VMAT is used instead of our standard 3D-CRT planning strategy. The amount of sparing that can be achieved strongly depends on the individual patient geometry. Whether this approach is able to conserve the neurocognitive status without compromising the oncological outcome for patients with glioblastoma needs to be investigated in the setting of prospective clinical trials. Purpose or Objective: Bone metastases are a frequent and disturbing complication of cancer. The challenge of optimizing dose coverage of the concave shape of the sacrum along with its close proximity to the rectum, intestines and femoral heads lead us to investigate whether the VMAT technique is advantageous when compared to 3D treatment.
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Material and Methods:
Twenty three consecutively treated patients with sacral metastases in 2013-2014 were included in a comparative treatment-planning study evaluating VMAT and 3-D planning. The statistical analysis included the Ttest, assuming Unequal Variance (one tail). Calculation of the p-value for the comparative results applied. Our null hypothesis was that VMAT is better than 3D technique, and our alternative hypothesis was that 3D technique is superior to VMAT.
Results:
The PTV coverage was identical in VMAT and 3D planning. Median values and V15 for the intestinal exposure showed no statistically significant difference between the 3D planning and VMAT: 9.28 Gy (SD 2.25) and 47.0 ml (SD 68.62) versus 8.97 Gy (SD 2.18) and 18.45 ml (SD 69.56), respectively. However, on an individual per case assessment it appears that the lower exposure of the bowel depends on the small bowel/ sacrum volumes ratio. The benefit for VMAT emerges if such a ratio exceeds one. The median values for the rectum 3D and VMAT were 11.34 Gy (SD 5.14) and 7.7 Gy (SD 2.76), respectively. The median 3D and VMAT exposure of the femoral head were 1.78 (SD 2.94) Vs 4.006 (SD 2.1) on the left and 1.74 (0.9) Vs 4.26 (SD 1.8) on the right side for the 3D and VMAT, respectively.
Conclusion:
Good sacral coverage is achievable with either 3-D or VMAT approaches. VMAT is advantageous vis-à-vis the rectal exposure and when relatively large amounts of small bowel course through an individual patient's fields. The 3-D approach, however, retains benefit for femoral protection, a finding that may have implications for patients with arthritis and osteopenia. for TBI is implemented in some centers. Compared to CRT, Tomotherapy allows the delivery of the prescribed dose with a high level of accuracy and homogeneity. Organs-at-risk can be spared and the dose distribution is known before the treatment. Two technical issues have to be solved. First, the patient must be treated using two plans, head first (HF) and feet first (FF) due to limited supero-inferior (SI) table motion. At the junction of these two plans, the dose must be delivered with particular care. Moreover, the planning target volume (PTV) is the entire body, including the skin. A safety margin in the air surrounding the body should be added to take into account setup errors. Using inverse planning, however, can result in over-fluence peaks in the skin region. The aim of this work is to present our solution for these two issues, our optimized planning protocol and our clinical results after one year of practice (outcome for 15 patients).
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